Tumor suppressor function of miR-129-5p in lung cancer

被引:32
|
作者
Li, Ge [1 ]
Xie, Jiahang [1 ]
Wang, Jiuhui [1 ]
机构
[1] Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, Sch Med, 55 South Renmin Rd, Chengdu 610041, Sichuan, Peoples R China
关键词
microRNA-129-5p; lung cancer; cell proliferation; apoptosis; MOLECULAR-PATTERN; DENDRITIC CELLS; HMGB1; PROLIFERATION; EXPRESSION; MIGRATION; INVASION; GROWTH; PROTEINS; RECEPTOR;
D O I
10.3892/ol.2019.10241
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung cancer causes severe health problems worldwide and, in China, besides being the principal cause of mortality among urbanites, it is the second leading cause of mortality in the rural population, preceded by hepatocellular carcinoma. Between 80 and 85% of lung cancer is classified as non-small cell lung cancer (NSCLC). The high mobility group box 1 (HMGB1) protein serves an important function in the tumor microenvironment and antitumor response, and may be targeted by microRNA (miR). In the present study, miR-129-5p was identified to target HMGB1 and miR-129-5p exhibited low expression levels in NSCLC tissues. Overexpression of miR-129-5p inhibited cell proliferation and promoted cell apoptosis. In conclusion, the results of the present study suggested the inhibitory function of miR-129-5p and revealed a novel therapeutic target for further investigation.
引用
收藏
页码:5777 / 5783
页数:7
相关论文
共 50 条
  • [31] MiR-129-5p inhibits non-small cell lung cancer cell sternness and chemoresistance through targeting DLK1
    Ma, Zheng
    Cai, Hongfei
    Zhang, Yan
    Chang, Liang
    Cui, Youbin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 490 (02) : 309 - 316
  • [32] LncRNA XIST promotes bladder cancer progression by modulating miR-129-5p/TNFSF10 axis
    Yu-Lin Kong
    Hui-Dan Wang
    Meng Gao
    Sheng-Zhong Rong
    Xiao-Xia Li
    Discover Oncology, 15
  • [33] MiR-129-5p is required for histone deacetylase inhibitor-induced cell death in thyroid cancer cells
    Brest, Patrick
    Lassalle, Sandra
    Hofman, Veronique
    Bordone, Olivier
    Tanga, Virginie Gavric
    Bonnetaud, Christelle
    Moreilhon, Chimene
    Rios, Geraldine
    Santini, Jose
    Barbry, Pascal
    Svanborg, Catharina
    Mograbi, Baharia
    Mari, Bernard
    Hofman, Paul
    ENDOCRINE-RELATED CANCER, 2011, 18 (06) : 711 - 719
  • [34] MiR-129-5p suppresses gastric cancer cell invasion and proliferation by inhibiting COL1A1
    Wang, Quan
    Yu, Jinhai
    BIOCHEMISTRY AND CELL BIOLOGY, 2018, 96 (01) : 19 - 25
  • [35] LncRNA LINC01278 Regulates the Prognosis and Related Mechanisms of Gastric Cancer by Targeting miR-129-5p
    Wang, Zhenhua
    Liu, Liyan
    Li, Zhengliang
    Liu, Xiaojing
    Wang, Jundong
    Wang, Jiaxi
    Jiang, Guoxiang
    Yu, Haizhou
    JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY, 2024, 43 (04) : 43 - 52
  • [36] MiR-129-5p contributes to BRAFi resistance development by targeting CDK6
    Gebhardt, K.
    Nemetschke, L.
    Sunderkotter, C.
    Gerloff, D.
    EXPERIMENTAL DERMATOLOGY, 2023, 32 (04) : E109 - E109
  • [37] MicroRNA profiling identifies miR-129-5p as a regulator of EMT in tubular epithelial cells
    Li, Yanlin
    An, Haiwen
    Pang, Jie
    Huang, Lin
    Li, Jinshan
    Liu, Linna
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (11): : 20610 - 20616
  • [38] Propofol Inhibits the Progression of Cervical Cancer by Regulating HOTAIR/miR-129-5p/RPL14 Axis
    Sun, Nai
    Zhang, Wei
    Liu, Jiaying
    Yang, Xiaochen
    Chu, Qinjun
    ONCOTARGETS AND THERAPY, 2021, 14 : 551 - 564
  • [39] mir-129-5p and Let-7 are Down-Regulated in Carcinoid Tumors
    Dossing, K.
    Binderup, T.
    Kaczkowski, B.
    Jacobsen, A.
    Winther, O.
    Rossing, M.
    Federspiel, B.
    Knigge, U.
    Kjaer, A.
    Friis-Hansen, L.
    NEUROENDOCRINOLOGY, 2012, 96 : 2 - 3
  • [40] Tumor suppressor role of miR-876-5p in gastric cancer
    Zhao, Hongwei
    Zheng, Yuzhu
    You, Jia
    Xiong, Jingyuan
    Ying, Shi
    Xie, Linshen
    Song, Xuejiao
    Yao, Yuqin
    Jin, Zhaohui
    Zhang, Chaoxiong
    ONCOLOGY LETTERS, 2020, 20 (02) : 1281 - 1287